Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature | Zendy

Eric J. Chow | Zendy; Branden Maust | Zendy; Katherine M. Kazmier | Zendy; Caleb Stokes | Zendy

Open Access

Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature

Author(s) -

Eric J. Chow,

Branden Maust,

Katherine M. Kazmier,

Caleb Stokes

Publication year - 2021

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piab029

Subject(s) - medicine , covid-19 , bradycardia , coronavirus , adverse effect , sinus bradycardia , disease , intensive care medicine , anesthesia , virology , heart rate , infectious disease (medical specialty) , blood pressure , outbreak

Remdesivir is an RNA polymerase inhibitor that is commonly used in the treatment of patients with severe acute coronavirus disease 2019 (COVID-19). As the severe acute respiratory syndrome coronavirus 2 spreads, the use of remdesivir is likely to increase. Most of the patients treated with remdesivir will not experience any adverse events although some side effects have been reported. Here, we describe a case of sinus bradycardia associated with remdesivir therapy in a pediatric patient with severe acute COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research